Prudential Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-69,272
| Closed | -$2.83M | – | 2442 |
|
|
2024
Q3 | $2.83M | Sell |
69,272
-4,227
| -6% | -$173K | ﹤0.01% | 1278 |
|
|
2024
Q2 | $2.83M | Buy |
73,499
+15,325
| +26% | +$590K | ﹤0.01% | 1221 |
|
|
2024
Q1 | $2.49M | Buy |
58,174
+8,117
| +16% | +$348K | ﹤0.01% | 1315 |
|
|
2023
Q4 | $1.86M | Buy |
50,057
+24,578
| +96% | +$911K | ﹤0.01% | 1481 |
|
|
2023
Q3 | $924K | Sell |
25,479
-672
| -3% | -$24.4K | ﹤0.01% | 1806 |
|
|
2023
Q2 | $932K | Buy |
26,151
+9,269
| +55% | +$330K | ﹤0.01% | 1839 |
|
|
2023
Q1 | $601K | Buy |
16,882
+6,517
| +63% | +$232K | ﹤0.01% | 1986 |
|
|
2022
Q4 | $364K | Sell |
10,365
-8,409
| -45% | -$295K | ﹤0.01% | 2161 |
|
|
2022
Q3 | $551K | Buy |
18,774
+2,328
| +14% | +$68.3K | ﹤0.01% | 2029 |
|
|
2022
Q2 | $900K | Buy |
16,446
+4,605
| +39% | +$252K | ﹤0.01% | 1844 |
|
|
2022
Q1 | $645K | Buy |
11,841
+6,746
| +132% | +$367K | ﹤0.01% | 2083 |
|
|
2021
Q4 | $274K | Buy |
+5,095
| New | +$274K | ﹤0.01% | 2439 |
|
|
2020
Q4 | – | Sell |
-7,320
| Closed | -$344K | – | 2478 |
|
|
2020
Q3 | $344K | Buy |
7,320
+2,271
| +45% | +$107K | ﹤0.01% | 2107 |
|
|
2020
Q2 | $257K | Buy |
5,049
+129
| +3% | +$6.57K | ﹤0.01% | 2166 |
|
|
2020
Q1 | $233K | Buy |
4,920
+462
| +10% | +$21.9K | ﹤0.01% | 2142 |
|
|
2019
Q4 | $262K | Buy |
+4,458
| New | +$262K | ﹤0.01% | 2253 |
|